Golimumab in Treatment-Refractory Hidradenitis Suppurativa

Дата публикации: 01-09-2026 00:00:00

This cohort study examines the association of a change in International Hidradenitis Suppurativa Severity Score System score with intravenously and subcutaneously administered golimumab in patients with moderate to severe hidradenitis suppurativa.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Golidocitinib for Folliculotropic Mycosis Fungoides	0	15.88	01-09-2026
2	Tuberculosis-Related Outcomes in Dermatologic Patients Receiving Systemic Therapy	0	10.27	01-09-2026
3	Patient Engagement With Dermatology Notes in the Electronic Patient Portal	0	9.2	01-09-2026
4	High-Dose Oral Vitamin D for Toxic Effects of the Skin Associated With Chemotherapy and Radiation	0	8.17	01-09-2026
5	A new era for difficult immune-mediated inflammatory diseases	0	11.06	21-09-2026
6	Enfortumab Vedotin−Induced Cutaneous Toxic Effects and Survival in Urothelial Carcinoma	0	6.29	01-09-2026
7	Consensus Guidelines for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma	0	4.08	01-09-2026
8	Postural Orthostatic Tachycardia Syndrome and Dermatomyositis	0	9.48	01-09-2026
9	Bilateral Conjunctival Cysts	0	10.41	24-09-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 7.71. Источник: archderm.jamanetwork.com.